secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK:        0001314052
Form:       8-K
Filed at:   2023-05-24T23:59:59+00:00
Accession:  0001731122-23-001007
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Anavex shareholders elect all six directors, ratify Grant Thornton LLP at 2023 annual meeting
--------------------------------------------------------------------------------

- 65% of outstanding shares (52.1M) represented at May 23, 2023 meeting.
- All six director nominees elected, including CEO Christopher Missling (24.8M for, 1.9M withheld).
- Ratification of Grant Thornton LLP as auditor passed with 51.1M for, 0.7M against, 0.3M abstain.
- No broker non-votes on auditor ratification; all directors had ~25.3M broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1314052/000173112223001007/0001731122-23-001007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1314052/000173112223001007/e4737_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-23-001007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer